Contrasting Auna (NYSE:AUNA) and Progyny (NASDAQ:PGNY)
by Sarita Garza · The Markets DailyProgyny (NASDAQ:PGNY – Get Free Report) and Auna (NYSE:AUNA – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.
Valuation and Earnings
This table compares Progyny and Auna”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Progyny | $1.17 billion | 1.85 | $54.34 million | $0.63 | 39.68 |
| Auna | $1.17 billion | 0.36 | $29.39 million | $0.71 | 8.01 |
Progyny has higher earnings, but lower revenue than Auna. Auna is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Progyny and Auna’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Progyny | 4.46% | 10.71% | 7.27% |
| Auna | 4.40% | 13.52% | 3.27% |
Insider & Institutional Ownership
94.9% of Progyny shares are held by institutional investors. 9.4% of Progyny shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings for Progyny and Auna, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Progyny | 0 | 3 | 9 | 1 | 2.85 |
| Auna | 1 | 2 | 2 | 1 | 2.50 |
Progyny currently has a consensus target price of $29.36, indicating a potential upside of 17.45%. Auna has a consensus target price of $7.30, indicating a potential upside of 28.30%. Given Auna’s higher probable upside, analysts plainly believe Auna is more favorable than Progyny.
Risk and Volatility
Progyny has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, Auna has a beta of 2.26, meaning that its stock price is 126% more volatile than the S&P 500.
Summary
Progyny beats Auna on 9 of the 14 factors compared between the two stocks.
About Progyny
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
About Auna
Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.